Monsanto Ordered To Take Deposition Of Man Dying From Cancer
Monsanto Ordered To Take Deposition Of Man Dying From Cancer

Introduction
U.S. District Judge Vince Chhabria of the Northern District of California, presiding over all Roundup lawsuits, issued a pretrial order on Wednesday, February 6, indicating that Monsanto must take the deposition of a man dying of non-Hodgkin’s lymphoma (NHL) within 28 days of the order. The federal judge also granted the man's request for an early trial considering his deteriorating health condition.
According to the lawsuit filed by the plaintiff in 2015, he was diagnosed with non-Hodgkin's lymphoma as a result of exposure to Roundup herbicide. In October 2018, his oncologist revealed that his cancer was spreading rapidly and he had less than six months to live. In November 2018, the plaintiff requested that his case must be given preference over other bellwether trials scheduled to begin that month, or remand it back to the Southern District of California, as he may not live enough to witness the outcome of the first bellwether trial. Judge Chhabria stated in the order that man's claim would be included in the second group of bellwether trials, and the pretrial schedule for those claims would be finalized after the conclusion of the first bellwether.
Monsanto faces a steady flow of Roundup lawsuits alleging that the herbicide's glyphosate ingredient causes cancer to humans. A California couple, both suffering from NHL, was granted an expedited trial, which is set to begin in March 2019. Additional trials are scheduled against Monsanto in Missouri also, including a multi-plaintiff trial involving claims filed by 15 individuals, which will go before the jury in October this year. More than 600 Roundup lawsuits are pending in the federal court system where Judge Vince Chhabria overlooks the consolidated lawsuits in the multidistrict litigation (MDL No. 2741; In re: Roundup Products Liability Litigation).
Latest News
Cencora Directors Settle Opioid Oversight Case for $111M
Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids…
Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients
A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…
FDA Adds New Warnings on Long-Term Opioid Risks
Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.
…